Mitochondria-associated gene expression perturbation predicts clinical outcomes and shows potential for targeted therapy in neuroblastoma
BackgroundMitochondria have long been considered a potential target in cancer therapy because malignant cells are known for their altered energy production. However, there is a lack of comprehensive research on the involvement of mitochondria-associated proteins (MAPs) in neuroblastoma (NB), and the...
Egile Nagusiak: | , , , , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Frontiers Media S.A.
2023-03-01
|
Saila: | Frontiers in Pediatrics |
Gaiak: | |
Sarrera elektronikoa: | https://www.frontiersin.org/articles/10.3389/fped.2023.1094926/full |